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Abstract
Background: Cysticercosis and hydatidosis seriously affect human health and are responsible for considerable economic
loss in animal husbandry in non-developed and developed countries. S3Pvac and EG95 are the only field trial-tested vaccine
candidates against cysticercosis and hydatidosis, respectively. S3Pvac is composed of three peptides (KETc1, GK1 and
KETc12), originally identified in a Taenia crassiceps cDNA library. S3Pvac synthetically and recombinantly expressed is
effective against experimentally and naturally acquired cysticercosis.
Methodology/Principal Findings: In this study, the homologous sequences of two of the S3Pvac peptides, GK1 and KETc1,
were identified and further characterized in Taenia crassiceps WFU, Taenia solium, Taenia saginata, Echinococcus granulosus
and Echinococcus multilocularis. Comparisons of the nucleotide and amino acid sequences coding for KETc1 and GK1
revealed significant homologies in these species. The predicted secondary structure of GK1 is almost identical between the
species, while some differences were observed in the C terminal region of KETc1 according to 3D modeling. A KETc1 variant
with a deletion of three C-terminal amino acids protected to the same extent against experimental murine cysticercosis as
the entire peptide. On the contrary, immunization with the truncated GK1 failed to induce protection. Immunolocalization
studies revealed the non stage-specificity of the two S3Pvac epitopes and their persistence in the larval tegument of all
species and in Taenia adult tapeworms.
Conclusions/Significance: These results indicate that GK1 and KETc1 may be considered candidates to be included in the
formulation of a multivalent and multistage vaccine against these cestodiases because of their enhancing effects on other
available vaccine candidates.
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Introduction
Parasitic zoonoses such as cysticercosis and hydatidosis seriously
affect human health and are responsible for considerable
economic loss in animal husbandry in developing and developed
countries [1]. Cestode lifecycles were established in their respective
hosts during the Pleistocene or earlier [2], and such long
coexistence has evolved into an intricate, multifaceted relationship.
To interrupt transmission of disease-causing cestodes to humans,
simultaneous and sustained implementation of far-reaching
measures and comprehensive social programs are required. These
include devising and implementing specific and general health
education programs, improving living conditions, and treating
tapeworm carriers, among others. Vaccination represents an
additional tool for control and prevention. Various whole or
subunit vaccine candidates have been tested with promising
protective effects against cysticercosis due to T. solium and T.
saginata, and against hydatid disease caused by E. granulosus and E.
multilocularis [3–10]. Their effectiveness, however, has been
assessed mostly in controlled experimental environments rather
than in complex natural conditions. Additionally, renewed hope
on the successful formulation of vaccines for the prevention of
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11287intestinal infections by adult Taenia species has recently emerged
[11–14].
Our research group developed the anti-cysticercosis S3Pvac
vaccine [15–18]. S3Pvac is composed of three peptides, namely
KETc12, KETc1, and GK1 of 8, 12, and 18 amino acids,
respectively. Their protective capacity was first observed in a T.
crassiceps murine cysticercosis model [16,17]. The peptides were
derived from native antigens present in different developmental
stages of T. crassiceps. Using specific antibodies it was found that
these peptides are also present in various T. solium anatomical
structures [16,17]. S3Pvac also induces significant protection
against cysticercosis in vaccinated pigs, both experimentally and in
the field where transmission conditions are most pressing [18]. It
also induces high levels of protection against experimental
tapeworm infection in hamsters [12].
A second S3Pvac version, S3Pvac-phage, has been developed by
expressing the peptides in filamentous phages [19]. S3Pvac-phage
reduced the frequency of tongue cysticercosis by 70%. A decrease
of 54% and 87% in pig infection frequency and in the number of
cysticerci, respectively, was detected in necropsies of 1,047 rural
pigs from 16 villages of central Mexico [20]. S3Pvac-phage is now
being produced massively and included in ongoing Mexican
regional control programs.
The extensive similarities among cestodes regarding their
natural history, pathology, and antigenic composition [21–23]
often allow us to extend the use of a protective antigen against one
species to others [5,24]. Besides, many antigens are shared among
the different developmental stages of cestodes (i.e. eggs, cysticerci,
tapeworms) [16,17,25,26]. These inter-species and inter-stage
shared antigens offer an interesting common target for vaccine
design. In this study, the homologous sequences of two of the
S3Pvac peptides were identified in different cestodes, including E.
granulosus, E. multilocularis, and T. saginata, with the aim of
developing a single vaccine against cysticercosis and hydatidosis.
Results
S3Pvac presence in the four cestodes
Figure 1 shows multiple alignments of deduced amino acid
sequences (A) and encoding DNA (B) for KETc1. For the sake of
simplicity, KETc1 alignment was divided into two regions: the first
includes the alignment before the KETc1 sequences, and the
second includes the vaccine peptide. In Region 1, three non-
synonymous mutations were found, as marked with arrows.
Region 2 (KETc1) shows six amino acid changes among the
different species and strains.
Figure1.MultiplesequencealignmentofKETc1peptides. TheDNAandaminoacidsequencesofKETc1ofseveralspeciesoftheTaeniidaefamily
were aligned. KETc1 alignments of amino acids (A) and cDNA (B) are shown in the upper part of the figure. On every alignment, boxes corresponding to
the regions subjected to dN/dS-ratio analysis are marked accordingly. Panel C and D shows the 3D models of the complete and truncated version of
KETc1. Panel D depicts the models corresponding to T. solium (red), T. crassiceps ORF and WFU (pink), T. saginata (light green) and Echinococcus group
(dark green). Structures are aligned with very good general agreement. Panel D shows the alignment of the truncated KETc1 peptide where the yellow
model corresponds to T. solium and T. saginata; blue corresponds to T. crassiceps ORF and WFU and brown to the Echinococcus group.
doi:10.1371/journal.pone.0011287.g001
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revealed signs of positive selection regions, which could indicate
that divergent evolution is taking place at these loci.
Figure 2 shows the multiple alignments of the highly conserved
sequence of GK1. One amino acid change was detected (big-
headed arrow), and seven synonymous mutations were found
(little-headed arrows). At the end of the alignment (Panels A and B)
a black line marks the end of the protein including the peptide.
The dN/dS analysis reveals signs of purifying selection acting on
these regions (dN/dS ,1).
3D structure prediction of KETc1 and GK1
Four models for KETc1 were constructed using the sequences
listed in Table 1. Panel C in Figure 1 shows the alignment of 3D
models corresponding to the whole peptide sequence for T. solium
(red), T. crassiceps ORF and WFU (pink), T. saginata (light green),
and the Echinococcus group (dark green). The five sequences are
evidently similar in their general structure, except those corre-
sponding to the Echinococcus group. These differences were
expected considering the differences at sequence level among
species. The models corresponding to the truncated version of
KETc1 are shown in panel D, while the model in yellow
corresponds to T. solium and T. saginata; brown corresponds to the
Echinococcus group and blue to T. crassiceps ORF and WFU. Here,
the sequence differences between T. solium and T. saginata
disappeared. Differences in sequence (and structure) still exist in
the case of T. crassiceps ORF and WFU and the Echinococcus group,
although for the latter, they are not reflected in the modeled 3D
structure (panel D).
The high conservation level in the amino acid sequence of GK1
is well reflected in the models shown in Panel C of Figure 2. The
two variants in the sequence of GK1, group the organisms in T.
solium, T. saginata, and E. granulosus and T. crassiceps ORF and
WFU, and E. multilocularis are shown. The model shows numerous
similarities in the structure of the GK1 peptide from different
cestodes.
S3Pvac expression in the four cestodes
Figures 3, 4 and 5 show the expression of KETc1 and GK1 in
the different cestodes and throughout the developmental stages of
Figure 2. Multiple sequence alignment GK1 peptides. The DNA and amino acid sequences of GK1 in several species of the Taeniidae family
were aligned. GK1 alignments of amino acids (A) and cDNA (B) are shown in the upper part of the figure; the region encoding the actual peptides is
marked with a double-headed arrow on the top of the alignment. On every alignment, boxes corresponding to the regions subjected to dN/dS-ratio
analysis are marked accordingly. Models of the 3D structure of the GK1 peptide are shown in panel C. The model in red corresponds to T. solium, T.
saginata and E. granulosus’ GK1 and in purple to T. crassiceps ORF and WFU and E. multilocularis. A very good fitting between the two structures is
shown as expected from the strong similarity of the amino acid sequence.
doi:10.1371/journal.pone.0011287.g002
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protein in the adult stage of T. crassiceps WFU, T. solium, and T.
saginata, and in T. solium oncospheres. GK1 was extensively
expressed in the tissues of the three adult stages of the species
analyzed. It was also localized in the parenchyma and tegument of
T. crassiceps; and in the distal cytoplasm (DC) region and the
perinuclear cytoplasm (PC) of T. saginata and T. solium tapeworms.
GK1 was also expressed in the oncosphere (O) of T. solium eggs.
KETc1 was only lightly detected in the medullar parenchyma
(MP) of adult tissues of T. crassiceps.I nT. saginata and T. solium,
KETc1 was detected mainly in DC, PE, and in the oncosphere.
Immunolocalization of the peptides in the larval phase of the
parasites is shown in Figure 4. The two peptides were present in
the cysticerci of both strains of T. crassiceps, but with different
localization. In the cysticerci of WFU strain, the three peptides
were located in MT, T, and P, while in those of ORF strain only
KETc1 was located in the tegument, specifically in the MT of the
tegument. In contrast, the two peptides were located in the
parenchyma. In T. solium cysticerci, GK1 presence in the tegument
of the spiral canal (TSC) and in tegument (T) seemed to be strong;
a similar distribution was observed when antibodies against GK1
were employed. In metacestodes of T. saginata, KETc1 was
detected in the parenchymal folds (PF) and lightly in TSC. GK1
was present in the parenchyma, but not in the TSC.
Both peptides were detected in the tegument of E. granulosus and
E. multilocularis, but with some differences (Figure 5). KETc1 was
more intensely detected than GK1 in E. multilocularis, whilst GK1
was the most conspicuous in E. granulosus.
Effect of truncation in the protective capacity of KETc1
and GK1 peptides
Differences in the three terminal amino acids were found
between Taenia and Echinococcus specimens of KETc1 and between
T. saginata and the other taenids. To evaluate the biological
relevance of these differences, a truncated version of KETc1, in
which the last three amino acids were deleted, was employed. As
Table 2 shows, the 9 amino acid-long new peptide maintained its
protective capacity when compared with the full-length peptide.
KETc1 and its truncated version significantly reduced the
expected number of cysticerci in 68.7 and 69.3%, respectively.
GK1 was almost identical in the different specimens tested.
However, considering that it is an 18-aa peptide, we decided to
evaluate the relevance of the terminal amino acid composition by
using a peptide including only the 10 first amino acids. Mice
immunized with GK1 reduced the expected number of cysticerci
by 71%, whilst the truncated GK1 did not reduce the number of
cysticerci compared to naı ¨ve control mice (Table 2).
All recovered cysticerci were vesicular and motile under the
stereoscopic microscope.
Discussion
The S3Pvac anti-cysticercosis vaccine, composed of three
peptides of 8 (KETc12), 12 (KETc1), and 18 amino acids (GK1)
[16,17,27], was first identified in a T. crassiceps strain ORF cDNA
library [28]. In this study we provide evidence indicating that two
of these peptides, KETc1 and GK1, are highly conserved among
different cestodes belonging to the genera Taenia (T. solium and T.
saginata) and Echinococcus (E. granulosus and E. multilocularis). These
results are not unexpected since extensive similarities among
cestodes [21–23] have been largely demonstrated in the past, and
offer the possibility of using the respective antigen homologues for
protecting against other cestodiases [5,24,29]. These similarities
observed among cestodes are encouraging, in particular consid-
ering that synthetically produced S3Pvac decreased the total
number of T. solium cysticerci (98.7%) and reduced the prevalence
(52.6%) of pig cysticercosis in different field trials performed in
rural communities of Mexico [15,18]. More recently, it has also
been proved that S3Pvac recombinantly expressed in M13
filamentous phages also reduced pig cysticercosis (54%) and the
number of established cysticerci by 87% [20]. Thus, these results
allow us to propose the possible efficacy of these peptides if they
are included in a multi-epitope vaccine against the aforementioned
cestodes that, as mentioned before, cause serious human ailments
and substantial economic loss to animal husbandry in developing
and developed countries. In order to improve vaccine efficiency
against cestodes, a vaccine formulation based on multistage
epitopes, such as GK1 and KETc1, should be considered. This
strategy has been successfully used against other parasitic diseases
[30]. Considering this purpose, it would also be of interest to
include the oncosphere TOVIS18 vaccine candidate. This
oncospheral antigen and its homologues in other taenids (TSOL18
and TSAG18/HP6 from T. solium and T. saginata, respectively)
exhibit substantial conservation of their gene structure. It has
Table 1. Sequences used to model the 3D structure of KETc1, GK1 and KETc12.
Peptide Organism Sequence
GK1 T. solium/T. saginata/E. granulosus vntAYYYPSDPNTFYAPPYSQ
T. crassiceps ORF/T. crassiceps WFU/E. multilocularis vntGYYYPSDPNTFYAPPYSQ
KETc1
1 T. crassiceps
2 ORF/WFU kpptldmrlrvtPMSTPSATSVR
T. solium tldmrlrvTPTSTPLATSVRkpp
T. saginata kpptldmrlrvTPTSTPLATLAR
E. multilocularis/E. granulosus kpptsdmrlrvTPTSTPSAISVQ
KETc1- truncated T. crassiceps ORF/WFU kpptldmrlrvTPMSTPSAT
T. solium/T. saginata/ kpptldmrlrvTPTSTPLAT
E. multilocularis/E. granulosus kpptsdmrlrvTPTSTPSAI
1GK1 and KETc1 3D models include more than just the peptide sequence because the HMMSTR-server requires sequences of at least 20 amino acids length. Upper case
marks the sequences of peptides while lower caps mark the preceding sequence to them.
2There is no ‘‘complete’’ sequence for any of the strains of T. crassiceps. However, considering the strong similarity between the Taenia species we decided to construct
a hypothetical sequence for each strain assuming that the preceding regions to KETc1 in T. crassiceps spp. are identical to those preceding the peptide in the other
Taenia species.
doi:10.1371/journal.pone.0011287.t001
Anti-Cestodiasis Vaccine
PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e11287recently been reported that TSOL18 induced an amazing 100%
of protection against the homologous infection [31]. Lower but still
significant protection of 74% was also induced when TOVIS18
was used in combination with two additional recombinant
vaccines against pig cysticercosis [5,29,31–34]. Taken together,
these results encourage us to propose the use of KETc1 and GK1,
and the respective HP6 homologues, in the design of polyvalent
vaccines against cestodes, considering their protective capacity,
and their presence in different cestode species and in different
parasite stages and structures. In addition, it would be possible to
kill oncospheres as well as early cysticerci, which may evade the
initial immune attack.
Looking closely at the homologous sequences described herein,
we found that most of the differences lie in the two strains of T.
crassiceps. Particularly, the ORF strain has unique point mutations
and major changes in the KETc1 reading frame. The latter causes
the introduction of non-sense codons in what appears to be an
open reading frame. Other point mutations are also found in
GK1. GK1 is a very well conserved peptide among the studied
species, but the surrounding region shows differences between the
ORF and WFU strains. However, based on the analysis of
available sequences, it is clear that, as in the case of KETc1, T.
crassiceps ORF may be the most divergent strain. This is not
completely unexpected, since the ORF strain was originally
obtained in 1962 [35] and has been reproduced by budding in the
peritoneal cavity of mice since then. This asexual multiplication
has resulted in the loss of the capacity for scolex production and of
two chromosomes [36]. These aberrations lead to the production
of sterile cysticerci, incapable of developing into adult tapeworms
in the definitive host [35]. This strain has been maintained at our
Institute and specifically for our research group under passage of
cysticerci in the peritoneal cavity of female BALB/cAnN mice
Figure 3. Immunolocalization of the S3Pvac peptides in larval specimens of the four Taeniidae families. Metacestode cryostat parasite
sections were incubated with a rabbit pre-immune serum (A) or with the three different rabbit antibodies (anti-GK1, anti-KETc1, anti-KETc12) and
developed with biotinylated goat anti-rabbit IgG plus streptavidin peroxidase conjugate and counterstained with hematoxilin. The arrows indicate the
areas in the metacestode where the peptides were localized. 10X (A and C), 40X (B and D). Tegument (T), parenchyma (P), tegument of the spiral canal
(TSC), parenchymal folds (PF), microthrix (MT), parenchyma (P). The three peptides are present in metacestode stage of four cestodes analyzed.
doi:10.1371/journal.pone.0011287.g003
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was recently isolated, and although it has also been maintained by
intraperitoneal passage, it has retained its capacity to develop into
the adult stage [38].
3D models of the peptides presented in this report were produced
using an ab-initio predicting tool. This means that every time a
sequence is modeled there are no assumptions on homology, and
the model is built ‘‘from scratch’’, based only on information from
physicochemical forces. Differences between molecules may arise
not only as a result of differences in sequence, but also as a
consequence of the modeling process itself. Nevertheless, we believe
that these models are a good information source, relevant for
vaccine design and functionality prediction. The 3D models of
KETc1 show some of the effects that changes in the amino acid
sequences could produce. Among the Taenia group sequences, that
of T. crassiceps ORF presents the most divergent structure. Such
differences persist even when a truncated version of the peptide is
modeled (Figure 1, Panel D), a circumstance under which all the
other peptides seem to adopt very similar configurations.
Murine T. crassiceps cysticercosis was used as a model to test the
biological significance of the differences in the KETc1 amino acid
content. This model has been extensively used to identify
promising antigens for vaccines against cysticercosis [24,28]. The
induced protection against murine cysticercosis using the truncat-
ed KETc1 is encouraging, and allows us to propose the use of a
new shortened peptide (9 amino acids) as part of a multipurpose
vaccine. Regarding GK1, truncation of the last ten amino acids
abolished its protective capacity. Nonetheless, since this peptide is
almost identical between the analyzed cestode species, the 18-aa
original version could be employed in a multipurpose polyvalent
vaccine against the different cestodiases.
The KETc1 sequence merits additional comments. The clone
that included KETc1 was identified by immunoscreening of a
cDNA library constructed in UNi-ZAP XR vector, and contained
an insert of 1.2 Kb. A rabbit antibody against a previously
identified protective antigen fraction [28] was initially used to
screen the library. KETc1 was then selected after being recognized
by pooled sera from cysticercotic pigs during a second screening
Figure 4. S3Pvac peptides were detected in the tegument of Taenia tapeworms and T. solium eggs. No reaction was detected in control
sections, for which naive rabbit serum was used in place of the specific polyclonal rabbit serum. S.- Sucker; Sc. Scolex, MP.- Medullar parenchyma,
N.- Neck; DC.- Distal cytoplasm region; PE.- perinuclear cytoplasm region. O.- oncospheres.
doi:10.1371/journal.pone.0011287.g004
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frame with the lacZ gene and the adaptor sequence including the
EcoRI restriction cloning site (GAATTCGGCACGAG) used to
clone the 5939 cDNA fragments in the lZAP vector revealed a stop
codon (TAA in T. solium and E. multilocularis and TGA in the others
cestodes) 12 amino acids downstream of the reading frame.
Despite this unexpected finding, the corresponding 11 amino-acid
peptide synthetically produced plus an alanine at the 59 end and a
glycine at the 39 end, demonstrated highly immunogenic
properties and induced high levels of protection when used as
immunogen against murine cysticercososis. This finding points to
the correct interpretation of these data [16,39].
Immunolocalization of the KETc1 and GK1 peptides provided
valuable information. The two peptides were localized in the
tegument of the adult and the larval stages of the different cestodes
(Fig. 3 to 5). This localization could be critically related to their
protective properties since the tegument is a metabolically active
layer responsible for nutrient absorption and digestion. It also
participates in defending the worm against the host’s digestive
enzymes. Furthermore, considering that the tegument’s function
and morphology is conserved in cestodes, it seems conceivable that
KETc1 and GK1 expression across species is quite uniform
[40,41]. Moreover, it is also probable that both peptides could be
detected in other organisms of medical relevance that belong to
this monophyletic cestode taxon i.e. Hymenolepis, Dyphillobotrium,
Spirometra [41,42]. In addition, KETc1 in T. crassiceps ORF is
detected in the outer surface of the tegument of the larval stage,
indicating its presence in the microtriches of the tegument. These
are ciliated sensory structures that increase the absorptive area of
the tapeworm [40,41,43].
The additional localization in the parenchyma could also be
related to critical parasite functions involved in the transport of
nutrients from the tegument to the inner organs. The expression of
these two epitopes in T. solium oncospheres should be noted since it
is a parasite stage highly susceptible to immune attack [44]. It is
highly feasible that these epitopes are also expressed in the
Figure 5. Immunolocalization of the S3Pvac peptides in E. granulosus and E. multilocularis. Sections of larval specimens reveal a strong
binding to the tegument (T) as well as in the parenchyma (P)o fE. multilocularis and in tegument of E. granulosus.( A) Control labeled with rabbit pre
immune serum. (B) Positive control labeled with polyclonal sera from rabbit immunized with a total extract of Taenia crassiceps ORF cysticerci.
doi:10.1371/journal.pone.0011287.g005
Table 2. Protection against experimental murine cysticercosis induced by T. crassiceps derived KETc1 or GK1 peptides or their
truncated analogs.
Individual number of cysticerci per mouse Mean ± SD
Naı ¨ve 186, 62, 189, 92, 5, 55, 101, 144, 149 109662.7
a
(non-immunized controls)
Mice immunized with:
KETc1 (APMSTPSATSVR) 0, 28, 14, 124, 0, 16, 72, 19 34.1642.8
b
KETc1 truncated (APMSTPSAT) 73, 0, 17, 0, 0, 6, 126, 46 33.5645.8
b
GK1(GYYYPSDPNTFYAPPYSA) 25, 22, 37, 63, 60, 1, 12 31.4623.4
b
GK1 truncated(GYYYPSDPNT) 1, 2, 95, 77, 2, 0, 135, 193 63.1674
a
Cysticerci were recovered 30 days after challenge. Different superscript letters indicate the statistically significant differences (P,0.05) by a Student’s t-test.
doi:10.1371/journal.pone.0011287.t002
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morphological similarities.
Importantly, besides the capacity to elicit specific immunity
[19,45], S3Pvac also elicits innate immunity by activating antigen-
presenting cells [46,47]. This finding reinforces the interest of
including these peptides in a polyvalent vaccine.
Altogether, these results support the possible efficacy of KETc1
and GK1 if included in the contents of a multivalent vaccine
against these cestodiasis. Further field trials using these two
peptides against different cestodiasis will support their effectiveness
in vaccination.
Materials and Methods
Ethics statement
Animal management for serum and parasite collection was
performed according to the principles set forth in the Guide for the
Care and Use of Laboratory Animals, Institute of Laboratory
Animal Resources, National Council, Washington, D.C. 1996.
This study was approved by the Ethics Committee of the Instituto
de Investigaciones Biome ´dicas, Universidad Nacional Auto ´noma
de Me ´xico (UNAM).
Parasites
The ORF strain of T. crassiceps has been maintained by serial
intraperitoneal passages in BALB/cAnN female mice for more
than 20 years at our Institute. Parasites for infections were
harvested from the peritoneal cavity of mice, 1–3 months after
inoculation of 10 cysticerci per mouse [37].
T. crassiceps WFU strain was isolated from a field mouse
(Peromyscus sp.) captured in the state of Michigan, USA in August
1999 by Dr. Raymond Kuhn and maintained by intraperitoneal
passage in female BALB/cAnN mice thereafter [48]. In December
1999 this strain was kindly donated by Dr. Kuhn to Dr. Kaethe
Willms of the Medicine Faculty at the Universidad Nacional
Auto ´noma de Me ´xico, and thereafter to our research group in
2007. Since then, it has been maintained by intraperitoneal
passage each 4–6 months by inoculation of 10 cysticerci using a
21G needle gauge. Cysticerci were recovered by cutting open the
abdominal wall, extracting them and washing them with sterile
saline solution. T. crassiceps WFU tapeworms were recovered by
dissection of the intestine of outbred golden hamsters (Mesocricetus
auratus) 20 days after oral infection with five cysts each.
T. solium cysticerci were dissected from skeletal muscle of highly
infected pork carcasses 2 to 4 h after slaughter in an abattoir in
Zacatepec, Morelos, Mexico. Segments from T. solium tapeworm
and eggs were obtained from the feces of an infected carrier as
previously described [16,17].
Taenia saginata cysticerci were recovered from slaughterhouses in
Guararapes, SP, Brazil from naturally infected cows identified
during sanitary inspection. The adult tapeworm was recovered
from a human carrier in Guerrero, Mexico, after specific medical
treatment.
E. granulosus specimens were obtained from the liver of naturally
infected pigs from slaughterhouses in the State of Morelos,
Mexico. Parasites were extensively washed with sterile saline
solution, dissected, and immediately stored in ethanol.
Metacestodes from E. multilocularis belonging to isolate H95
were recovered from experimentally infected Mongolian jirds
(Meriones unguiculatus).
Extraction of Genomic DNA (gDNA)
Metacestode genomic DNA from the ORF and WFU strains of
T. crassiceps, T. solium, E. granulosus, and T. saginata which were
excised from infected mice, pigs and cattle respectively, and purified
using GenomicPrep kit (GE, Buckinghamshire, UK) following the
protocol for DNA isolation of animal tissue. E. multilocularis DNA
was isolated following a method reported elsewhere [49].
PCR amplification and DNA sequencing
All PCR reactions were performed in a final volume of 50 ml,
containing 5 mlo f1 0 6 PCR buffer (Invitrogen, Carlsbad, CA,
USA) and 1 ml 100 mM deoxynucleoside triphosphates (Invitro-
gen), 1.7 ml of magnesium chloride, 1 ml of the corresponding
forward and reverse primers at a concentration of 20 ng/ml and
0.5 ml of Taq DNA polymerase (Invitrogen). Five hundred
nanograms of genomic DNA were used for each reaction. A
positive control was employed consisting of the original sequences
that codified for the respective peptides cloned in the plasmids
pSK or pUI 235-5.1.
Primers employed for amplification of the homologous sequences
of KETc1, and GK-1 (which is inserted into the KETc7 sequence)
(Genbank Accession Number U31524) are shown in Table 3. A
Palm Cycler (Corbett Life Science, Sydney, Australia) was used for
amplification, and it included a denaturation cycle at 94uC for
3 min; 35 cycles at 94uC for 15 s, 30 s at the optimum annealing
temperature for each peptide, and 72uC for 30 s. A final extension
cycle at 72uC for 7 min was included. Optimum annealing
temperatures were for KETc1 54uC and GK1 52uC. Amplification
products were analyzed on a 2% agarose gel and visualized in UV
light by ethidium bromide staining. DNA bands corresponding to
the expected molecular weights were excised and purified using the
QIAEX II kit (Qiagen).
Sequencing was done either in an ABI PRISM 310 Genetic
Analyzer PE at the Instituto de Investigaciones Biome ´dicas,
UNAM or in a Perkin Elmer/Applied Biosciences 3730 at the
Instituto de Biotecnologı ´a, also at UNAM.
Sequence analysis
Amino acid sequence alignments were performed using
ClustalW/X 2.0 [50], T-Coffee [51], and BLAST[52]. cDNA
Table 3. Primers used for PCR amplification of the KETc1 and GK-1 (KETc7) homologous sequences in T. crassiceps ORF, T.
crassiceps WFU, T. solium, T. saginata, E. multilocularis, and E. granulosus.
Peptide Primers Sequences (59-39)
KETc1 KETc1 2294 GCTCCAATGTCTACACCAT
K1b-AS Universidad Nacional Auto ´noma de Me ´xico, Distrito Federal, Me ´xico,
GK-1 Sense primer GCATTTATGCAGCCGCATCCTTCC
A05 CTAAAGATTCTTCTTATCTTCTGGTTCCAT
doi:10.1371/journal.pone.0011287.t003
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naked eye to make them consistent with those of amino acids using
Seaview and eBiox/eBiotools.
dN/dS ratio determination was performed using codeml and
YN00 from the PAML (v.4.2) package by Ziheng Yang [53,54].
KETc1 cDNA and cDNA-derived amino acid alignments were
divided in two parts to minimize the noise produced by sequence
ambiguities (i.e, not all sequences are of the same size, (see
Figure 1). For the sequence corresponding to GK1, only the bases
that encode this peptide plus three previous amino acids were
analyzed (Figure 2).
Genomic and cDNA sequences were translated to amino acids
using Expasy’s Translate Tool; the corresponding reading frame
was determined based on the presence of the reported sequences
for KETc1 and KETc7. Resulting sequences were compared to
reported ones from T. solium (UNAM) and E. multilocularis (Sanger
Institute) genomes using BLAST [52].
Accession numbers of the sequences are: for KETc7 in T.
crassiceps ORF (Genbank Accession Number U31524), in T. solium
(UNAM) (Genbank accession number EL745878), in T. saginata
(Genbank Accession Number HM010764) and in T. crassiceps
WFU (Genbank Accession Number HM010765). For KETc7 in
E. multilocularis the homologues sequences were identified from the
database of Echinococcus project (www.sanger.ac.uk/Projects/Echi-
nococcus/), (Sanger Institute), contig 0011155 (subsequence 472–
1560) and for E. granulosus (Genbank Accession Number
HM010766),
For KETc1 in Taenia crassiceps ORF (Genbank Accession
Number HM010769), in T. solium (UNAM) (Genbank accession
number EL740346), in T. saginata (Genbank Accession Number
HM010767) and in T. crassiceps WFU (Genbank Accession
Number HM010768). Data for E. granulosus and E. multilocularis
were downloaded from the database of Echinococcus project (www.
sanger.ac.uk/Projects/Echinococcus/), (23187935 and contig
0006325 (subsequence 49202–49933), respectively).
Peptide 3D-structure prediction
The 3D-structures of the relevant regions containing the
conserved protection-inducing motifs were modeled using the
HMMSTR Ab-initio prediction server [55,56].
Results were obtained as .pdb files and further analyzed using
Swis-PdbViewer and eBiox/eBiotools for MacOs X. Table 1
shows the sequences used to perform this analysis.
Antibodies
Specific rabbit anti-KETc1 and anti-GK1 antisera were
prepared by immunization of one white female New Zealand
rabbit for each. Rabbits were bled before subcutaneous immuni-
zation with 100 mg of each synthetic peptide in Freund’s
incomplete adjuvant (Sigma), 5 times each 15 days. Ten days
after the last immunization rabbits were bled and their sera were
collected. The presence of specific antibodies was tested by ELISA
using the respective synthetic peptides as antigens. The presence of
specific antibodies was monitored by ELISA during the immuni-
zation schedule using the synthetic peptides as source of antigen
according to a previously reported procedure, with minor
modifications [17]. Polystyrene plates were irradiated with UV
light prior to coating the target synthetic peptide to improve
peptide attachment to the solid phase [57].
Immunolocalization of the S3Pvac peptides
The distribution of S3Pvac peptides in the different cestodes was
analyzed considering that it could provide information concerning
their potential physiological functions in these parasites. The
different parasite specimens were fixed and stained mainly
following the procedure described by Montero et al., 2007 [58].
Specific rabbit antibodies were prepared as described above and
employed as primary antibody. Non-specifically bound host
proteins were dissociated from the different cestodes using a
previously described procedure [27]. Briefly: vesicular fluid was
obtained from cysts, washed thoroughly with ice cold PBS, and
incubated with 50 mM glycine–HCl, pH 2.5; 0.1% Triton X-100;
0.15mMNaCl for 30 s. pH was restored by adding Tris–HCl,
pH 9, followed by incubation in Zamboni solution for 72 hours.
Afterwards the specimens were embedded in paraffin and six
micrometer sections were cut. Slides were placed on poly-l-lysine
(Sigma)-treated microslides. Peroxidase activity was blocked by
treatment with 3% H2O2 in PBS for 10 min at room temperature.
After washing with PBS, the slides were blocked with 5% BSA in
PBS plus 0.1% Triton X-100 (pH 7.4) for 1 h at 37uC. Solutions
were removed and the slides were incubated overnight at 4uC with
sera from pre-immune rabbits and T. crassiceps infected mice, or
specific rabbit antibodies against GK1 and KETc1 prepared as
described above. These sera were employed as the primary
antibody at a dilution of 1:1000 in 1% BSA in PBS plus 0.1%
Triton X-100 (PBS/A-T). After washing three times in PBS/A-T,
5 min each, the slides were covered with a biotinylated goat anti-
mouse IgG (ImmunO Universal Kit, MP Biomedicals, Eschwege,
Germany) for 30 min at 37uC, rinsed with PBS/A-T, and treated
with streptavidin-peroxidase conjugate (HRP conjugated, Univer-
sal Kit, MP Biomedicals, Eschwege, Germany) for 30 min at
37uC. Peroxidase activity was visualized by incubating the samples
with 393-diaminobenzidine (DAB-Plus Kit, Zymed, South San
Francisco, CA.). The slides were counterstained with Mayer’s
hematoxylin, dehydrated, cleared, mounted, and observed with an
optical microscope (Nikon) using the MetaMorph Imaging System
4.5 software.
Mice immunization and challenge
In order to determine the relevance of the few differences found
between peptides regarding their protective capabilities, full
sequences of GK1 and KETc1 and their respective truncated
versions were tested for their protective capacity using a murine
model of cysticercosis, which has been extensively employed to
identify antigens of interest for vaccination. Eight female mice per
experimental group, bred and kept in our animal facilities, were
used for vaccine trials. The experiments reported herein were
conducted according to the principles set forth in the Guide for the
Use of Laboratory Animals, Institute of Laboratory Animal
Resources, National Research Council, Washington, DC, 1996.
The experimental protocols were approved by the Animal Care
Committee of the Universidad Nacional Auto ´noma de Me ´xico
and the Guide for Care and Use of Experimental Animals was
followed.
BALB/cAnN mice were subcutaneously immunized with
10 mg/mouse of KETc1, GK1, and their respective truncated
peptides. Immunization was performed twice at 10-day intervals.
Fifteen days after the second immunization, naı ¨ve and immunized
mice were intraperitoneally challenged with 15 non-budding
cysticerci of T. crassiceps (2 mm in diameter), in 0.9 ml of PBS. To
determine the level of protection, mice were sacrificed thirty days
after infection and the cysts inside the peritoneal cavity were
harvested and counted under a stereoscopic microscope.
Peptides
The T. crassiceps derived peptides KETc1 (APMSTPSATSVR)
and GK1 (GYYYPSDPNTFYAPPYQ) were synthetically pro-
duced by AnaSpec Inc. A truncatedpeptideof KETc1: AlaProMet
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Tyr Tyr Tyr Pro Ser Asp Pro Asn Thr (GYYYPSDPNT) were
synthesized by AnaSpec Inc. Peptide puritywas .95% as judgedby
HPLC.
Statistical Analysis
Statistical comparison of individual parasite intensities between
groups was performed by Student’s t-test. All statistical analyses
were performed by the Instat software program (GraphPad, San
Diego,Calif.). P,0.05 was considered statistically significant.
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